Amplifon SpA
LSE:0N61
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (2.9), the stock would be worth €19.67 (112% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.4 | €9.29 |
0%
|
| 3-Year Average | 2.9 | €19.67 |
+112%
|
| 5-Year Average | 3.4 | €23.47 |
+153%
|
| Industry Average | 1.8 | €12.28 |
+32%
|
| Country Average | 1.5 | €10.54 |
+13%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
€3.2B
|
/ |
Jan 2026
€2.4B
|
= |
|
|
€3.2B
|
/ |
Dec 2026
€2.5B
|
= |
|
|
€3.2B
|
/ |
Dec 2027
€2.8B
|
= |
|
|
€3.2B
|
/ |
Dec 2028
€3B
|
= |
|
|
€3.2B
|
/ |
Dec 2029
€2.9B
|
= |
|
|
€3.2B
|
/ |
Dec 2030
€3.1B
|
= |
|
|
€3.2B
|
/ |
Dec 2031
€3.2B
|
= |
|
|
€3.2B
|
/ |
Dec 2032
€3B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
|
Amplifon SpA
LSE:0N61
|
2.1B EUR | 1.4 | 22.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.3B USD | 0.3 | 23.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 0.2 | 36.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.5B USD | 0.2 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
45.5B USD | 0.2 | 27.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 2.9 | 35.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.3 | 11.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.9 | 21.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.5B CNY | 1.7 | 20.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.6B HKD | 0 | 7.2 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 0.8 |
| Median | 1.5 |
| 70th Percentile | 2.9 |
| Max | 54 933.7 |
Other Multiples
Amplifon SpA
Glance View
Amplifon SpA, a global leader in hearing solutions, crafts its story around a mission to enhance auditory experiences for individuals worldwide. The company, founded in 1950 by Algernon Charles Holland in Milan, Italy, began as a modest venture but evolved into a dominant force in the audiology market. Amplifon operates through an extensive network of clinics and service centers, boasting a widespread presence across Europe, the Americas, Asia-Pacific, and Africa. Each location serves as a hub where highly trained audiologists and specialists offer personalized hearing assessments and consultations. This localized approach allows the company to cater uniquely to each customer's needs, delivering tailored solutions such as hearing aids, devices, and accessories from leading brands, as well as a suite of supportive services. The company's business model effectively harnesses a comprehensive and vertically integrated structure. Amplifon generates revenue by not just selling hearing devices, but also by providing related services like fittings, aftercare, and support. This approach creates a recurring income stream, as customers often require ongoing maintenance and upgrades to their devices. Additionally, Amplifon invests heavily in research and development, ensuring its offerings incorporate the latest technological advancements. By focusing on innovation and customer satisfaction, Amplifon maintains strong relationships with both its suppliers and clientele, fortifying its position in the competitive landscape of hearing solutions. Through a combination of strategy, service, and an unwavering commitment to quality, the company continues to expand its influence and drive growth in the global market.